10-K Filing

RX TECHNOLOGIES CORP. CIK: 1453086 FY 2011

Filing Information

Form Type	10-K
Accession Number	`0001161697-12-000095`
Period End Date	20111231
Filing Date	20120223
Fiscal Year	2011
Fiscal Period	FY
XBRL Instance	rxt-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 45 Cash Flow Statement 70 Stockholders Equity 28

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	-	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	-	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	55.82M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	78.12M	shares	Point-in-time
Gift Card Digest Website, net	`FiniteLivedMediaContentGross`	-	USD	Point-in-time
Gift Card Digest Website, net	`FiniteLivedMediaContentGross`	$1.83K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	78.12M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	55.82M	shares	Point-in-time
RxTC Solutions, net	`FiniteLivedContractualRightsGross`	$37.22K	USD	Point-in-time
RxTC Solutions, net	`FiniteLivedContractualRightsGross`	$10.00K	USD	Point-in-time
Medipayments, net	`OtherFiniteLivedIntangibleAssetsGross`	$10.00K	USD	Point-in-time
Medipayments, net	`OtherFiniteLivedIntangibleAssetsGross`	-	USD	Point-in-time
Total Other Assets	`AssetsNoncurrent`	$39.06K	USD	Point-in-time
Total Other Assets	`AssetsNoncurrent`	$20.00K	USD	Point-in-time
Total Assets	`Assets`	$20.00K	USD	Point-in-time
Total Assets	`Assets`	$39.06K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	-	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	-	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$7.25K	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$7.40K	USD	Point-in-time
Advances from Related Parties	`DueToRelatedPartiesCurrent`	$5.70K	USD	Point-in-time
Advances from Related Parties	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$12.95K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$7.40K	USD	Point-in-time
Total Long-term Liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total Long-term Liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$7.40K	USD	Point-in-time
Total Liabilities	`Liabilities`	$12.95K	USD	Point-in-time
Preferred Stock, par value $.001; 10,000,000 shares authorized; 0 issued and outstanding at December 31, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, par value $.001; 10,000,000 shares authorized; 0 issued and outstanding at December 31, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $.001; 500,000,000 shares authorized; 78,121,850 shares issued and outstanding at December 31, 2011; 55,821,850 shares issued and outstanding as of December 31, 2010	`CommonStockValue`	$78.12K	USD	Point-in-time
Common stock, par value $.001; 500,000,000 shares authorized; 78,121,850 shares issued and outstanding at December 31, 2011; 55,821,850 shares issued and outstanding as of December 31, 2010	`CommonStockValue`	$55.82K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$132.60K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$43.40K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$67.57K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$203.67K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$3.71K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$7.05K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$31.66K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$5.83K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	-	USD	Point-in-time
Total Liabilites and Stockholder's Equity/(Deficit)	`LiabilitiesAndStockholdersEquity`	$39.06K	USD	Point-in-time
Total Liabilites and Stockholder's Equity/(Deficit)	`LiabilitiesAndStockholdersEquity`	$20.00K	USD	Point-in-time

Income Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net Sales	`SalesRevenueNet`	-	USD	Annual
Net Sales	`SalesRevenueNet`	-	USD	Annual
Net Sales	`SalesRevenueNet`	-	USD	13 Qtrs
Cost of Sales	`CostOfGoodsAndServicesSold`	-	USD	Annual
Cost of Sales	`CostOfGoodsAndServicesSold`	-	USD	Annual
Cost of Sales	`CostOfGoodsAndServicesSold`	-	USD	13 Qtrs
Gross Profit	`GrossProfit`	-	USD	13 Qtrs
Gross Profit	`GrossProfit`	-	USD	Annual
Gross Profit	`GrossProfit`	-	USD	Annual
General & Administrative	`GeneralAndAdministrativeExpense`	$7.05K	USD	Annual
General & Administrative	`GeneralAndAdministrativeExpense`	$17.82K	USD	13 Qtrs
General & Administrative	`GeneralAndAdministrativeExpense`	$8.28K	USD	Annual
Legal and Accounting	`ProfessionalFees`	$35.62K	USD	13 Qtrs
Legal and Accounting	`ProfessionalFees`	$10.00K	USD	Annual
Legal and Accounting	`ProfessionalFees`	$15.00K	USD	Annual
Fees To Directors	`FeesToDirectors`	$25.00K	USD	13 Qtrs
Fees To Directors	`FeesToDirectors`	$10.00K	USD	Annual
Fees To Directors	`FeesToDirectors`	$15.00K	USD	Annual
Consulting, Marketing and Advertising	`MarketingAndAdvertisingExpense`	$12.00K	USD	Annual
Consulting, Marketing and Advertising	`MarketingAndAdvertisingExpense`	$77.00K	USD	13 Qtrs
Consulting, Marketing and Advertising	`MarketingAndAdvertisingExpense`	$65.00K	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$2.00K	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$1.83K	USD	Annual
Amortization	`AmortizationOfIntangibleAssets`	$6.00K	USD	13 Qtrs
Impairment	`AssetImpairmentCharges`	-	USD	Annual
Impairment	`AssetImpairmentCharges`	$42.22K	USD	13 Qtrs
Impairment	`AssetImpairmentCharges`	$42.22K	USD	Annual
Total Expenses	`OperatingExpenses`	$203.67K	USD	13 Qtrs
Total Expenses	`OperatingExpenses`	$52.27K	USD	Annual
Total Expenses	`OperatingExpenses`	$136.11K	USD	Annual
Net (loss) before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-136.11K	USD	Annual
Net (loss) before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-52.27K	USD	Annual
Net (loss) before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-203.67K	USD	13 Qtrs
Provision for Income Taxes	`IncomeTaxExpenseBenefit`	-	USD	13 Qtrs
Provision for Income Taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for Income Taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net (loss)	`NetIncomeLoss`	$-136.11K	USD	Annual
Net (loss)	`NetIncomeLoss`	$-203.67K	USD	13 Qtrs
Net (loss)	`NetIncomeLoss`	$-3.17K	USD	1 Quarter
Net (loss)	`NetIncomeLoss`	$-12.12K	USD	Annual
Net (loss)	`NetIncomeLoss`	$-52.27K	USD	Annual
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.00	USD	Annual
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.00	USD	Annual
Weighted average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne`	35.36M	shares	Annual
Weighted average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne`	63.28M	shares	Annual

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-136.11K	USD	Annual
Net loss	`NetIncomeLoss`	$-203.67K	USD	13 Qtrs
Net loss	`NetIncomeLoss`	$-3.17K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.12K	USD	Annual
Net loss	`NetIncomeLoss`	$-52.27K	USD	Annual
Increase in amortization	`AmortizationOfIntangibleAssets`	$6.00K	USD	13 Qtrs
Increase in amortization	`AmortizationOfIntangibleAssets`	$1.83K	USD	Annual
Increase in amortization	`AmortizationOfIntangibleAssets`	$2.00K	USD	Annual
Issuance of common stock for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$25.00K	USD	Annual
Issuance of common stock for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$95.00K	USD	13 Qtrs
Issuance of common stock for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$70.00K	USD	Annual
Conversion of related shareholders advances	`ConversionOfRelatedShareholdersAdvances`	$16.50K	USD	13 Qtrs
Conversion of related shareholders advances	`ConversionOfRelatedShareholdersAdvances`	$16.50K	USD	Annual
Conversion of related shareholders advances	`ConversionOfRelatedShareholdersAdvances`	-	USD	Annual
Impairment loss	`AssetImpairmentCharges`	$42.22K	USD	13 Qtrs
Impairment loss	`AssetImpairmentCharges`	$42.22K	USD	Annual
Impairment loss	`AssetImpairmentCharges`	-	USD	Annual
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	-	USD	13 Qtrs
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$-2.00K	USD	Annual
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	-	USD	Annual
Increase/(decrease) in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	-	USD	Annual
Increase/(decrease) in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	-	USD	13 Qtrs
Increase/(decrease) in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	-	USD	Annual
Increase/(decrease) in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$7.25K	USD	13 Qtrs
Increase/(decrease) in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$6.90K	USD	Annual
Increase/(decrease) in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-150.00	USD	Annual
Acquisition of intellectual property	`IncreaseDecreaseInIntangibleAssetsCurrent`	-	USD	Annual
Acquisition of intellectual property	`IncreaseDecreaseInIntangibleAssetsCurrent`	$6.00K	USD	13 Qtrs
Acquisition of intellectual property	`IncreaseDecreaseInIntangibleAssetsCurrent`	-	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.38K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-42.70K	USD	13 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.70K	USD	Annual
Increase in equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Increase in equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	13 Qtrs
Increase in equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	13 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Issuance of common stock for cash	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Issuance of common stock for cash	`ProceedsFromIssuanceOfCommonStock`	$19.00K	USD	13 Qtrs
Issuance of common stock for cash	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Increase in due to related parties	`ProceedsFromRelatedPartyDebt`	$23.70K	USD	13 Qtrs
Increase in due to related parties	`ProceedsFromRelatedPartyDebt`	$16.38K	USD	Annual
Increase in due to related parties	`ProceedsFromRelatedPartyDebt`	$5.70K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.38K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.70K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$42.70K	USD	13 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	-	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	-	USD	13 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	-	USD	Annual
CASH BEGINNING BALANCE	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH BEGINNING BALANCE	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH BEGINNING BALANCE	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH BEGINNING BALANCE	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH ENDING BALANCE	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH ENDING BALANCE	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH ENDING BALANCE	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH ENDING BALANCE	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Taxes paid	`IncomeTaxesPaid`	-	USD	13 Qtrs
Taxes paid	`IncomeTaxesPaid`	-	USD	Annual
Taxes paid	`IncomeTaxesPaid`	-	USD	Annual
Interest paid	`InterestPaid`	-	USD	13 Qtrs
Interest paid	`InterestPaid`	-	USD	Annual
Interest paid	`InterestPaid`	-	USD	Annual
Issuance of common stock for purchase of intellectual property	`IssuanceOfCommonStockForAcquisitionOfIntellectualProperty`	$25.00K	USD	Annual
Issuance of common stock for purchase of intellectual property	`IssuanceOfCommonStockForAcquisitionOfIntellectualProperty`	$37.22K	USD	Annual
Issuance of common stock for purchase of intellectual property	`IssuanceOfCommonStockForAcquisitionOfIntellectualProperty`	$62.22K	USD	13 Qtrs
Repayment of related party loan with stock	`RepaymentOfRelatedPartyLoanWithStock`	$18.00K	USD	13 Qtrs
Repayment of related party loan with stock	`RepaymentOfRelatedPartyLoanWithStock`	$18.00K	USD	Annual
Repayment of related party loan with stock	`RepaymentOfRelatedPartyLoanWithStock`	-	USD	Annual

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Common stock issued, price per share	`EquityIssuanceDollarAmountPerShare`	$0.01	USD	Point-in-time
Balance	`StockholdersEquity`	$3.71K	USD	Point-in-time
Balance	`StockholdersEquity`	$7.05K	USD	Point-in-time
Balance	`StockholdersEquity`	$31.66K	USD	Point-in-time
Balance	`StockholdersEquity`	$5.83K	USD	Point-in-time
Balance	`StockholdersEquity`	-	USD	Point-in-time
Common stock issued	`StockIssuedDuringPeriodValueNewIssues`	$9.00K	USD	1 Quarter
Common stock issued	`StockIssuedDuringPeriodValueNewIssues`	$10.00K	USD	Annual
Common stock issued on April 30, 2010 for Rx Technologies/Intellectual Property	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$37.22K	USD	Annual
Common Stock issued for: Acquistion of Medipayment	`StockIssuedDuringPeriodValueAcquisitions`	$25.00K	USD	Annual
Common Stock issued for: Consultants	`StockIssuedDuringPeriodValueConsultantsOne`	$10.00K	USD	Annual
Common Stock issued for: Advances from related parties	`StockIssuedDuringPeriodValueAdvancesFromRelatedPartiesOne`	$7.50K	USD	Annual
Common Stock issued for: Advances from related parties	`StockIssuedDuringPeriodValueAdvancesFromRelatedPartiesOne`	$18.00K	USD	Annual
Common Stock issued for: Directors Fees	`StockIssuedDuringPeriodValueDirectorsFees`	$15.00K	USD	Annual
Common Stock issued for: Directors Fees	`StockIssuedDuringPeriodValueDirectorsFees`	$10.00K	USD	Annual
Common Stock issued for: Consutling and Services rendered	`StockIssuedDuringPeriodValueConsultantsAndServices`	$10.00K	USD	Annual
Common Stock issued at June 30, 2011 for advances from related party	`StockIssuedDuringPeriodValueAdvancesFromRelatedPartiesTwo`	$9.00K	USD	Annual
Common Stock issued for: Consultants	`StockIssuedDuringPeriodValueConsultantsTwo`	$50.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-136.11K	USD	Annual
Net loss	`NetIncomeLoss`	$-203.67K	USD	13 Qtrs
Net loss	`NetIncomeLoss`	$-3.17K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.12K	USD	Annual
Net loss	`NetIncomeLoss`	$-52.27K	USD	Annual
Balance	`StockholdersEquity`	$3.71K	USD	Point-in-time
Balance	`StockholdersEquity`	$7.05K	USD	Point-in-time
Balance	`StockholdersEquity`	$31.66K	USD	Point-in-time
Balance	`StockholdersEquity`	$5.83K	USD	Point-in-time
Balance	`StockholdersEquity`	-	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.